| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | Australia | 3 | |
| #3 | Canada | 2 | |
| #4 | Republic of Korea | 2 | |
| #5 | Mexico | 2 | |
| #6 | Singapore | 2 | |
| #7 | EPO (European Patent Office) | 1 | |
| #8 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Medical technology | |
| #5 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Microorganisms | |
| #3 | Therapeutic chemical compounds | |
| #4 | Climate change adaptation technologies | |
| #5 | Peptides | |
| #6 | Implantable devices | |
| #7 | Enzymes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Alving Carl R | 6 |
| #2 | Rao Mangala | 4 |
| #3 | Beck Zoltan | 4 |
| #4 | Kim Jerome H | 3 |
| #5 | Hauns Kevin D | 2 |
| #6 | Carl R Alving | 2 |
| #7 | Alving Carl | 2 |
| #8 | Chivukula Padmanabh | 2 |
| #9 | Alemayehu Saba | 2 |
| #10 | Ahmed Farheen | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2018237339A1 | Nyvac-based plasmodium malaria vaccine | |
| EP3600396A1 | Nucleic acid vaccine composition comprising a lipid formulation, and method of increasing the potency of nucleic acid vaccines | |
| WO2018175712A1 | Recombinant adeno-associated virus-paraoxonase 1-ifii particles and the methods of making and using thereof | |
| WO2018169785A2 | Therapeutic antibodies to marburg virus | |
| WO2017210215A1 | Zika virus vaccine and methods of production | |
| KR20170007242A | Non-toxic adjuvant formulation comprising a monophosphoryl lipid a (mpla)-containing liposome composition and a saponin |